Literature DB >> 11979137

Use of complementary therapies by patients with IBD may indicate psychosocial distress.

Louise Langmead1, Meenali Chitnis, David S Rampton.   

Abstract

BACKGROUND: Complementary and alternative medicine (CAM) is used increasingly by patients with chronic diseases. We have assessed the use of CAM in general medicine and gastrointestinal outpatients focusing particularly on factors predisposing to its use in patients with inflammatory bowel disease (IBD).
METHODS: 239 consecutive patients attending gastrointestinal and general medical outpatient clinics answered a questionnaire about their use of CAM: patients with IBD also completed a validated disease-specific quality of life (QOL) inflammatory bowel disease questionnaire (IBDQ).
RESULTS: 26% of all patients used CAM, most commonly herbal remedies (43%). CAM was used significantly more by younger than older patients and by single than married or widowed ones. There were no differences by gender or ethnicity. More patients with irritable bowel syndrome used CAM than those with other diagnoses. In IBD patients, CAM users had significantly poorer QOL scores for emotional and social factors than nonusers. 53% of users stated that CAM alleviated their symptoms.
CONCLUSIONS: Use of CAM is common in gastroenterological outpatients, particularly if they are young, single, or have irritable bowel syndrome (IBS). Most patients deem it helpful. In IBD, poor QOL predisposes to use of CAM. Conversely, use of CAM may serve as a marker of emotional or social unease in these patients. Physicians need to be aware of widespread usage of CAM by their patients.

Entities:  

Mesh:

Year:  2002        PMID: 11979137     DOI: 10.1097/00054725-200205000-00003

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  21 in total

1.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.

Authors:  Réme Mountifield; Jane M Andrews; Antonina Mikocka-Walus; Peter Bampton
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Complementary and alternative medicine for functional gastrointestinal disorders.

Authors:  K Tillisch
Journal:  Gut       Date:  2006-05       Impact factor: 23.059

3.  Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire.

Authors:  Wen-Wei Huang; Fu-sheng Zhou; Donald M Bushnell; Chiaka Diakite; Xiao-huan Yang
Journal:  Qual Life Res       Date:  2007-04-12       Impact factor: 4.147

Review 4.  Dietary factors in the modulation of inflammatory bowel disease activity.

Authors:  Shinil Shah
Journal:  MedGenMed       Date:  2007-03-27

5.  Quality of life of participants in a mind-body-based self-development course: a descriptive study.

Authors:  Lotta Fernros; Anna-Karin Furhoff; Per E Wändell
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

Review 6.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 7.  Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?

Authors:  Anna Matheis; Ute Martens; Johannes Kruse; Paul Enck
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

Review 8.  Herbal medicine in the treatment of ulcerative colitis.

Authors:  Fei Ke; Praveen Kumar Yadav; Liu Zhan Ju
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

9.  Complementary and Alternative Therapies for Functional Gastrointestinal Diseases.

Authors:  Jiande D Z Chen; Jieyun Yin; Toku Takahashi; Xiaohua Hou
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-04       Impact factor: 2.629

10.  Use of complementary and alternative medicine: a survey in Turkish gastroenterology patients.

Authors:  Taylan Kav
Journal:  BMC Complement Altern Med       Date:  2009-10-26       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.